Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleFirst drug for short-bowel.AuthorsDorey, EmmaAbstractThe article offers information on the approval of Gattex (teduglutide), a first-in-class, ultra-orphan therapy for treating adults with short-bowelsyndrome (SBS), by the U.S. Food and Drug Administration (FDA) on December 21, 2012.SubjectsDRUG approval; UNITED States. Food &; Drug Administration; SHORT bowel syndrome; THERAPEUTICSPublicationNature Biotechnology, 2013, Vol 31, Issue 2, p92ISSN1087-0156Publication typeArticleDOI10.1038/nbt0213-92b